IR情報

2024/11/28~2025/04/28

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2025
04/281,4521,4621,4281,435+3.84%9,907,9002兆5968億+4.14%
04/2515:30 条件付対価に関わる公正価値変動額の計上および2025年3月期連結業績予想と実績値との差異について
04/2515:30 2025年3月期決算補足資料
04/2515:30 2025年3月期決算説明会資料
04/2515:30 2025年3月期決算短信[IFRS](連結)
04/251,3741,3891,3671,382+1.54%5,515,4002兆5009億+0.14%
04/241,3681,3751,3561,361-0.51%5,031,7002兆4629億-1.73%
04/231,3781,3791,3571,368+1.33%4,657,9002兆4756億-1.58%
04/221,3331,3501,3241,350+1.05%3,721,0002兆4430億-3.23%
04/211,3481,3491,3281,336-1.26%3,499,9002兆4177億-4.57%
04/181,3481,3531,3291,353+1.96%3,358,0002兆4484億-3.7%
04/171,3211,3281,3141,327+0.3%3,912,8002兆4014億-5.89%
04/161,3301,3351,3151,323-1.05%4,777,6002兆3941億-6.5%
04/151,3321,3501,3281,337+1.83%5,711,4002兆4195億-5.85%
04/141,2901,3231,2901,313+3.39%5,497,8002兆3760億-7.86%
04/111,2541,2771,2521,270-4.8%10,637,5002兆2982億-11.19%
04/101,3501,3611,3211,334+6.13%10,732,5002兆4140億-7.3%
04/091,3281,3321,2441,257-6.26%13,738,4002兆2747億-12.95%
04/081,3301,3441,3151,341+3%9,629,9002兆4267億-7.64%
04/071,3001,3371,2741,302-6.33%11,695,0002兆3561億-10.64%
04/041,3721,4081,3721,390+1.02%10,137,5002兆5154億-4.99%
04/031,3751,3891,3651,376-1.99%11,161,9002兆4900億-6.14%
04/021,4511,4571,4031,404-3.9%8,677,0002兆5407億-4.55%
04/011,4611,4731,4551,461+0.97%5,137,8002兆6439億-0.95%
03/311,4611,4641,4421,447-2.1%7,584,8002兆6185億-1.9%
03/281,4681,4831,4671,478-1.66%7,099,2002兆6746億+0.2%
03/271,4921,5041,4891,503+0.47%8,775,8002兆7199億+1.97%
03/261,5101,5131,4911,496-0.27%6,444,4002兆7072億+1.56%
03/251,5021,5101,4941,500-0.13%5,859,9002兆7144億+1.83%
03/241,5061,5131,5021,502+0.54%5,173,3002兆7181億+2.04%
03/211,4751,5091,4701,4940%13,285,1002兆7036億+1.49%
03/191,4851,5011,4851,494+0.67%6,940,5002兆7036億+1.63%
03/181,4921,4951,4841,484+0.27%5,453,7002兆6855億+1.09%
03/171,4741,4861,4671,480+0.82%3,775,2002兆6783億+0.95%
03/141,4461,4731,4461,468+0.62%6,953,1002兆6565億+0.2%
03/131,4531,4631,4501,459+0.07%4,370,2002兆6402億-0.27%
03/121,4461,4581,4351,458+0.83%6,420,8002兆6384億-0.41%
03/111,4551,4641,4441,446-0.96%8,560,4002兆6167億-1.3%
03/101,4601,4711,4591,460+0.21%4,442,2002兆6421億-0.48%
03/071,4591,4681,4531,457-1.02%7,105,7002兆6366億-0.88%
03/061,4761,4921,4711,472+0.14%5,535,7002兆6638億-0.07%
03/051,4581,4851,4541,470+0.82%6,518,8002兆6602億-0.41%
03/041,4631,4771,4551,458-0.21%7,507,2002兆6384億-1.35%
03/031,4711,4751,4551,461+0.48%4,600,6002兆6439億-1.22%
02/281,4751,4861,4471,454-1.69%10,190,2002兆6312億-1.76%
02/271,4871,5001,4771,479-0.67%4,382,2002兆6764億-0.14%
02/261,5041,5051,4891,489-0.4%5,026,0002兆6945億+0.47%
02/251,4661,4981,4661,495+1.98%5,199,2002兆7054億+0.88%
02/211,4591,4741,4591,466+0.83%3,289,5002兆6529億-1.08%
02/219:00 サステナビリティ・ミーティング資料(2024年度)
02/201,4551,4681,4441,454-0.62%5,126,1002兆6312億-1.96%
02/191,4681,4731,4571,463-0.88%4,649,8002兆6475億-1.55%
02/181,4761,4871,4731,476-0.07%3,024,7002兆6710億-0.81%
02/171,4811,4901,4761,477-0.81%3,607,9002兆6728億-0.87%
02/141,5031,5181,4771,489-0.33%9,077,6002兆6945億-0.2%
02/131,4791,5101,4751,494+3.11%8,845,2002兆7036億+0.07%
02/138:30 IZERVAY(avacincaptad pegol)米国で添付文書一部変更に関する承認を取得
02/121,4481,5121,4191,449-0.28%20,083,5002兆6222億-3.08%
02/101,4401,4621,4291,453+1.32%6,959,0002兆6294億-3%
02/071,4271,4441,4231,434+0.07%4,386,3002兆5950億-4.46%
02/061,4321,4451,4261,433+0.35%5,584,0002兆5932億-4.85%
02/051,4711,4731,4151,428-3.84%12,620,4002兆5841億-5.43%
02/058:30 個別決算(日本基準)における特別損失の計上について
02/0415:30 2025年3月期第3四半期決算説明会資料
02/0415:30 2025年3月期第3四半期決算補足資料
02/0415:30 2025年3月期第3四半期決算短信[IFRS](連結)
02/041,4821,5041,4791,485+0.88%5,221,9002兆6873億-1.92%
02/031,5001,5041,4711,472-2.84%7,698,8002兆6638億-2.84%
01/311,5291,5301,5131,515-0.92%5,353,7002兆7416億-0.13%
01/301,5321,5351,5191,529-0.2%3,348,5002兆7669億+0.72%
01/291,5351,5371,5201,532-0.45%5,297,7002兆7724億+0.92%
01/281,5331,5531,5271,539+1.32%5,634,6002兆7850億+1.45%
01/271,5091,5281,5071,519+1.13%6,081,2002兆7488億+0.2%
01/2416:00 コアビジネスの進展、減損損失の計上および通期業績予想の修正について
01/241,5001,5151,4931,502+1.62%4,080,6002兆7181億-0.99%
01/231,4771,4821,4611,478-0.54%4,945,1002兆6746億-2.7%
01/221,4931,4981,4841,486-0.13%4,282,3002兆6891億-2.43%
01/211,4901,4981,4841,488+0.13%2,979,0002兆6927億-2.49%
01/201,4941,4971,4761,486-0.54%5,536,0002兆6891億-2.88%
01/171,5041,5071,4901,494-0.73%5,580,8002兆7036億-2.61%
01/161,5251,5261,5051,505-1.57%4,719,8002兆7235億-2.15%
01/151,5391,5601,5291,529+0.79%7,174,4002兆7669億-0.78%
01/141,5141,5231,5021,517+0.46%8,152,2002兆7452億-1.75%
01/101,5301,5361,5071,510-1.69%8,082,2002兆7325億-2.45%
01/091,5221,5451,5141,536+0.99%6,352,5002兆7796億-0.97%
01/098:30 IZERVAY(avacincaptad pegol) FDAがクラス1の一部変更承認の再申請を受理
01/081,5321,5411,5211,521-1.04%4,685,8002兆7524億-2%
01/071,5351,5441,5281,537+0.65%4,581,5002兆7814億-1.09%
01/061,5351,5371,5171,527-0.52%7,168,1002兆7633億-1.86%
2024
12/301,5491,5511,5331,535-0.65%5,159,6002兆7778億-1.41%
12/271,5301,5501,5301,545+0.98%5,433,5002兆7959億-0.9%
12/261,5171,5301,5171,530+0.59%4,790,9002兆7687億-1.86%
12/251,5401,5411,5141,521-0.65%4,191,5002兆7524億-2.56%
12/241,5251,5351,5161,531+0.79%3,981,1002兆7705億-2.05%
12/231,5301,5341,5081,519-1.56%5,027,3002兆7488億-2.88%
12/201,5281,5451,5261,543+1.51%9,307,4002兆7923億-1.59%
12/191,5071,5261,5021,520+0.66%4,881,4002兆7506億-3.37%
12/181,5101,5171,5051,510-0.46%5,961,8002兆7325億-4.37%
12/171,5171,5241,5071,517-0.65%7,153,4002兆7452億-4.35%
12/161,5531,5561,5221,527-1.93%5,263,8002兆7633億-4.14%
12/131,5531,5701,5471,557-1.58%7,713,4002兆8176億-2.81%
12/121,5761,5891,5741,582+0.44%4,357,9002兆8628億-1.62%
12/111,5781,5931,5711,575-0.38%4,426,4002兆8502億-2.42%
12/101,5991,6001,5751,581-0.13%3,738,5002兆8610億-2.47%
12/091,5811,5931,5761,583+0.13%3,362,9002兆8646億-2.7%
12/061,5911,5961,5761,581-0.75%3,658,2002兆8610億-3.3%
12/051,6041,6081,5881,593-0.81%3,855,8002兆8827億-3.04%
12/041,6071,6091,5951,606-0.86%4,088,4002兆9063億-2.73%
12/031,6001,6251,5951,620+2.27%6,375,2002兆9316億-2.29%
12/021,5701,5891,5641,584+1.41%4,225,1002兆8665億-4.75%
11/291,5601,5701,5491,562-0.64%5,503,4002兆8266億-6.41%
11/281,5631,5741,5551,572+0.32%3,743,4002兆8447億-6.26%